Doceree Bags $35M to Lead the Way in Innovative HCP Marketing

Doceree, a global network for healthcare professionals (HCPs) specializing in programmatic messaging, has successfully raised $35 million in a Series B funding round to revolutionize HCP marketing. The funding injection will empower Doceree in its innovative health solutions and expand its global presence, positioning it as a leader in the rapidly evolving field of HCP marketing.

Creaegis, a prominent digital and technology investment firm, led the round, with participation from existing investors Eight Roads Ventures and F-Prime Capital.

Doceree, founded in 2019 by Harshit Jain, has been unwavering in its commitment to transforming HCP marketing worldwide. The funds will empower the company to expedite product development, enhance its technological infrastructure, facilitate global expansion, and strengthen its team.

“We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US, but also elsewhere in the same vein,” said Harshit Jain MD, Founder & Global CEO, Doceree.

Remarkable Growth and Innovative Solutions

Over the past year, Doceree has achieved remarkable growth, with monthly revenue skyrocketing fivefold since its Series A funding round in April 2022. The company’s success is due to its pioneering solutions for pharmaceutical and life sciences companies and healthcare media agencies.

Doceree’s innovative approach includes the introduction of category-first innovations on both the demand and supply sides. It encompasses the launch of Doceree Enterprise, a specialized global Demand Side Platform (DSP) tailored for HCPs and Doceree Providers, designed to empower healthcare professionals to improve patient health outcomes.

These solutions form part of Doceree’s comprehensive HCP marketing ecosystem, which equips life science marketers with the tools to engage physicians strategically and evaluate campaign performance, ultimately enhancing script lift.

“The pharma messaging space is evolving quickly, and our solutions are aligned to meet the immediate requirements of the life sciences industry. We are growing massively and have a competitive edge. We are thrilled about the future as we continue to expand and touch new horizons in the space,” added Harshit Jain.

Global Expansion and Tailored Solutions

Recognizing the enthusiastic reception of its offerings in the US, India, and European markets, Doceree has extended its reach to new territories, including Africa, Southeast Asia (SEA), and the Gulf Cooperation Council (GCC). The company has meticulously curated and iterated its solutions to cater to the unique needs of marketers in these regions.

Looking ahead, Doceree will launch a series of smart and interconnected solutions that promise to bring transformative change to the global healthcare ecosystem. These products will enable precision targeting of HCPs, enhancing communication at various touchpoints in physicians’ professional and clinical journeys.

“Doceree’s technology platform allows biopharmaceutical companies to connect with physicians like never before. The company’s impressive growth trajectory results from its unique, data-driven approach to enabling communication with precision and relevance,” said Ashish Venkataramani, Partner, Eight Roads Ventures.

Doceree’s latest funding milestone, led by Creaegis and joined by established investors, underscores the company’s commitment to revolutionizing HCP marketing worldwide.

Stay ahead of the curve and follow IndiaTechDesk on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in India.